What Royan Institute does

Royan Institute (پژوهشگاه رویان) is an Iranian multi-disciplinary biomedical research and clinical organization headquartered in Tehran, operating under the Islamic Azad University (جهاد دانشگاهی) system. Founded on 8th Khordad 1370 (May 28, 1991) by Dr. Saeed Kazemi Ashtiani, the institute was originally established as a limited surgery center to provide infertility treatment alongside research and education in reproductive sciences. Over three decades it has expanded into an integrated ecosystem spanning four research institutes (reproductive sciences, stem cell biology and technology, biotechnology in Isfahan, and cancer), four specialized treatment centers (infertility, cell therapy, diabetes/obesity/metabolism, and comprehensive genetics), education facilities including the Faculty of Basic Medical Sciences and Advanced Medical Technologies, and commercialization units (ATMP Development Center, Biotechnology Growth Center incubator, RITAC accelerator, and knowledge-based spin-off companies).

The institute generates revenue across five distinct streams: clinical and medical services delivered through its four treatment centers; health tourism via a dedicated International Patients Department (IPD); education and training programs including degree courses, short-term training, and the International Royan Summer School; scientific publishing through two peer-reviewed journals (Cell Journal and IJFS); and technology commercialization via knowledge-based (دانش‌بنیان) spin-offs and ATMP product development. Dual regulatory recognition — medical research center licenses from the Ministry of Health (1998 and 2008) and Research Institute status from the Ministry of Science (November 2009) — underpins its operations. It claims the first IVF birth in Iran, hosts the International Royan Congress, International Royan Festival, and Kazemi Prize, and operates multilingual (English/Arabic) websites to support international patient and research outreach. The organization is government-affiliated rather than privately funded, with approximately 887 employees, no disclosed equity funding, and no M&A activity in the available record.

Name

Royan Institute

Legal name

پژوهشگاه رویان (Royan Institute)

Website

https://royaninstitute.org

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Royan Institute is an Iranian biomedical research and clinical organization operating four research institutes and four treatment centers focused on reproductive sciences, stem cell biology, biotechnology, genetics, and related specialized medical services, including health tourism.

Ownership category

akta.pro rank

Product category

Reproductive Medicine and Biomedical Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Family Planning Centers (621410), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

akta.pro secondary industries

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Diabetes (General) (HLAKADAA)

Keywords

• Reproductive medicine services
• Stem cell research
• Infertility treatment
• Genetic testing services
• Biomedical research institute

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Clinical and Medical Services: Revenue from providing specialized medical treatments including infertility services, cell therapy, diabetes/metabolism care, and genetic testing to patients. Services are delivered through the Advanced Infertility Treatment Center, Cell Therapy Center, Diabetes Center, and Genetics Center.
2. Health Tourism (IPD): Revenue from international patients seeking advanced reproductive and medical treatments in Iran, supported by a dedicated international patients unit.
3. Education and Training Programs: Revenue from the Faculty of Basic Sciences and Advanced Medical Technologies, short-term training courses, summer schools, and the Stem Cell Education Center — covering both academic degree programs and professional development courses.
4. Scientific Publications: Revenue from publishing Cell Journal and IJFS (International Journal of Fertility and Sterility) scientific journals.
5. Technology Commercialization: Revenue from knowledge-based (دانش‌بنیان) companies spin-offs, ATMP product development, and the biotechnology growth center ecosystem that commercializes research outputs.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Royan Institute is a multi-disciplinary biomedical research and healthcare organization that delivers advanced reproductive medicine (IVF/ICSI/infertility treatment), cell and regenerative therapies, diabetes and metabolic disorder care, and comprehensive genetic testing and counseling through four specialized treatment centers in Tehran. It concurrently operates four research institutes (reproductive sciences, stem cell biology and technology, biotechnology, and cancer), an educational faculty and training programs, ATMP product development, and two peer-reviewed scientific journals (Cell Journal and IJFS).

Product overview

Royan Institute is a multi-disciplinary research and healthcare organization comprising multiple interconnected divisions. The institute operates through four main pillars: (1) Treatment Activities: Super-specialized infertility treatment center, cell therapy center, diabetes/obesity/metabolism center, and comprehensive genetics center; (2) Research Activities: Four research institutes covering reproductive sciences, stem cell biology and technology, biotechnology, and cancer; (3) Education: Faculty of basic medical sciences and advanced technologies, short-term training courses, and stem cell education center; (4) Commercialization: ATMP development center, biotechnology growth center (incubator), and RITAC innovation accelerator. Additional activities include international conferences and festivals, scientific publications (Cell Journal, IJFS), laboratory animal services, and medical ethics consulting. The institute was founded in 1991 by Dr. Saeed Kazemi Ashtiani under Iran's Jihad Daneshgahi.

Differentiator

Problem solved

Functional benefit

Brands

• Royan Infertility Center: Super-specialized infertility treatment center
• Royan Cell Therapy Center
• ATMP Development Center
• RITAC
• Cell Journal
• IJFS (International Journal of Fertility System)

Products and services

• Royan Infertility Treatment Center (مرکز فوق تخصصی درمان ناباروری) A super-specialized center providing advanced infertility diagnosis and treatment services including IVF, ICSI, embryo transfer, reproductive surgery, and fertility preservation, serving infertile couples and individuals in Iran.
• Royan Cell Therapy Center (مرکز سلول درمانی) A specialized center focused on cell therapy treatments and research, delivering stem cell-based and regenerative medicine interventions to patients with conditions treatable through advanced cellular therapies.
• Royan Diabetes, Obesity and Metabolism Center (مرکز دیابت، چاقی و متابولیسم) A specialized center dedicated to the treatment and research of diabetes, obesity, and metabolic disorders, serving patients with chronic metabolic conditions.
• Royan Comprehensive Genetics Center (مرکز جامع ژنتیک رویان) A comprehensive genetics center offering full-spectrum genetic testing, diagnosis, and counseling services including carrier screening, prenatal diagnosis, and reproductive genetic risk assessment for individuals and families.
• Royan Comprehensive Stem Cell Center (مرکز جامع سلول‌های بنیادی) A comprehensive stem cell center providing stem cell related medical services to patients in regenerative medicine and cellular therapy contexts.
• Health Tourism / International Patients Department (IPD) A dedicated International Patients Department (IPD) coordinating advanced reproductive and specialized medical treatment for international patients traveling to Iran, including treatment planning, intake coordination, and travel/logistics support.
• Cell Journal

Quantifiable outcome

• First IVF birth in Iran achieved by Royan Institute (established as the pioneering reproductive medicine center in the country)
• +2 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles7 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• University of Science and Culture (دانشگاه علم و فرهنگ)notableStrategic or Co-development Partner · 24 August 1405The 17th International Royan Summer School (August 2026 / 24–28 Mordad 1405) is being co-organized by Royan Institute and the University of Science and Culture in Tehran. The summer school will focus on 'Microbiome and Regenerative Medicine' under the theme 'Symphony of Treatment; Unleashing Regeneration Potential with Microbiome'. This represents a mutual academic collaboration for educational program delivery.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Natera: Genetic testing company specializing in reproductive health (carrier screening, NIPT, preimplantation genetic testing). Comparable to Royan's Comprehensive Genetics Center offerings in prenatal and reproductive genetic diagnostics.
• MyHeritage / Gene by Gene: Genetic testing and ancestry services with consumer-facing genetic health tests. Partial overlap with Royan's genetic testing and counseling services, though oriented to consumer genetic health rather than reproductive-focused testing.

Broad incumbents

• BGI Group: China-based genomics and cell therapy company operating genetic testing, reproductive health (NIPT, carrier screening), and stem cell research programs. Comparable to Royan's Comprehensive Genetics Center plus reproductive sciences overlap, though at much larger scale.
• CooperCompanies (CooperSurgical): Large diversified medical device company with significant exposure to fertility, genomics, and reproductive medicine through CooperSurgical. Comparable as a broad incumbent offering overlapping fertility and genetic testing capabilities across a wider healthcare portfolio.
• Karolinska Institutet: Sweden-based leading medical research university with strong reproductive medicine and stem cell research programs. Comparable to Royan as a research-institute structured organization spanning biomedical research, education, and clinical translation.

Direct peers

• Vitrolife: Global provider of IVF media, consumables, and reproductive medicine services. Comparable as a vertically integrated player in the IVF value chain, though commercially focused rather than research-institute structured like Royan.
• Genea Biomedx: Developer of assisted reproductive technology products and IVF laboratory systems. Comparable to Royan's embryology and reproductive technology capabilities, particularly the technology commercialization track via spin-offs and ATMP development.
• Prelude Fertility: U.S.-based fertility clinic network offering IVF, egg freezing, and reproductive endocrinology services. Comparable to Royan's infertility treatment center in terms of clinical service portfolio for assisted reproductive technology.
• Monash IVF Group: Asia-Pacific leading fertility services provider operating IVF clinics and reproductive medicine research programs. Comparable to Royan's reproductive medicine treatment center and ART services, though operating in a private-equity-backed commercial model rather than a state-affiliated research institute structure.
• CCRM (Colorado Center for Reproductive Medicine): Network of fertility clinics and IVF research centers in North America, specializing in advanced reproductive endocrinology and embryology. Directly comparable to Royan's IVF and reproductive sciences capabilities with integrated clinical-research infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/school/royan-institute

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries27 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Royan Institute